Le Lézard
Classified in: Health

Robins & Morton, St. Joseph's Hospital Celebrate Expansion Topping Out


TAMPA, Fla., Sept. 13, 2019 /PRNewswire-PRWeb/ -- St. Joseph's Hospital, Robins & Morton, HOK Architecture, Carastro Engineering and honored guests joined together to celebrate the structural topping out of the St. Joseph's Hospital patient tower expansion located in Tampa, Florida, on Sept. 10.

The expansion project will include a new six-story patient tower that will house a two-story lobby, waiting and on-call rooms and three patient care floors with 90 private patient rooms. A new bridge will connect St. Joseph's Hospital to St. Joseph's Women's Hospital, allowing for patient transport from one facility to the other.

"Robins & Morton is proud to partner with BayCare and St. Joseph's Hospital on this exciting project," Robins & Morton Senior Superintendent Steve Williams said. "The scope of this project connects St. Joseph's Hospital, St. Joseph's Children's Hospital and St. Joseph's Women's Hospital, providing safe and efficient pedestrian paths between all three facilities. We look forward to completing this exciting addition, ensuring BayCare and St. Joseph's Hospital continues to provide superior healthcare services to the Tampa community."

The patient tower expansion is scheduled to be completed in mid-2020.

About Robins & Morton
Robins & Morton is a privately-held, innovation-driven construction firm committed to Building with Purpose®. Since 1946, the firm has built a reputation as a trusted advisor to clients nationwide by cultivating a high-performing team that values integrity, safety, and innovative thinking. Robins & Morton consistently ranks among the Top 100 U.S. Builders in Engineering News-Record. Robins & Morton is based in Birmingham, Alabama, with additional offices in Charlotte, North Carolina; Dallas, Texas; Huntsville, Alabama; Miami and Orlando, Florida; Nashville, Tennessee. Learn more at http://www.robinsmorton.com.

 

SOURCE Robins & Morton


These press releases may also interest you

at 20:35
La Jolla Institute for Immunology and RevolKa started a Research Collaboration
RevolKa Ltd. (Norio Hamamatsu, President & CEO), a venture-backed biotech company providing a game-changing protein engineering technology platform and La Jolla Institute for Immunology (LJI) (Erica Saphire, President & CEO) agreed to start a...

at 19:05
U.S. FDA Approves Subcutaneous Administration of Takeda's ENTYVIO® (vedolizumab) for Maintenance Therapy in Moderately to Severely Active Crohn's Disease
Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved ENTYVIO® (vedolizumab) subcutaneous (SC) administration for maintenance therapy in adults with moderately to severely active Crohn's disease (CD)...

at 18:42
Media Advisory - Minister Saks in Winnipeg to highlight Budget 2024: Fairness for Every Generation investments to boost research funding in Canada
The Honourable Ya'ara Saks, Minister of Mental Health and Addictions and Associate Minister of Health, will host an event at the University of Manitoba to highlight the federal budget's investments to boost funding for research in Canada. A media...

at 18:18
Targeting A Solution Panel Aims to Find Solutions for the Veteran Suicide Crisis with National Thought Leaders Tulsi Gabbard, Tim Kennedy, and Dan Hollaway
Targeting a Solution is an insightful and impactful fireside discussion dedicated to ending Veteran suicide that will have its next iteration on April 20th, 2024, in Kannapolis, NC hosted by The Independence Fund. The panel will feature four-term...

at 18:15
Equality Health Foundation Expands Reach to Virginia and Louisiana
Equality Health Foundation, the philanthropic partner of Equality Health LLC and an organization dedicated to advancing health equity and improving well-being access for underserved communities, proudly announces its expansion into Virginia and...

at 18:01
Aflac Incorporated Revises Time of First Quarter Webcast Teleconference to 7:00 a.m. (ET) on Thursday, May 2, 2024
Aflac Incorporated announced today that it has revised the time of its first quarter webcast teleconference call on Thursday, May 2, 2024 to 7:00 a.m. (ET), which is one hour earlier than the originally scheduled 8:00 a.m. start time, to avoid...

More news about Health...


News published on and distributed by: